This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Kaneka Corporation. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Mitsuji Akazawa: Innovator in Pharmaceutical Formulations
Introduction
Mitsuji Akazawa is a notable inventor based in Takasago, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 2 patents, Akazawa's work focuses on enhancing the stability and effectiveness of pharmaceutical products.
Latest Patents
Akazawa's latest patents include a formulation comprising an active pharmaceutical ingredient and a patch designed for fast-acting anesthetic action. The first patent addresses a formulation that includes ethyl cellulose, an active pharmaceutical ingredient, and a solvent. This formulation is designed to be stable, suppressing the generation of impurities even during long-term storage. The second patent presents a patch that combines a mixture of lidocaine and another local anesthetic, ensuring practical adhesive and cohesive forces while providing rapid anesthetic effects.
Career Highlights
Mitsuji Akazawa has been associated with Kaneka Corporation, where he has contributed to various innovative projects. His expertise in pharmaceutical formulations has positioned him as a key player in the industry. His work is characterized by a commitment to improving the quality and efficacy of medical products.
Collaborations
Throughout his career, Akazawa has collaborated with talented individuals such as Masaya Mizutani and Tatsuyoshi Tanaka. These collaborations have fostered a creative environment that encourages innovation and the development of groundbreaking solutions in pharmaceuticals.
Conclusion
Mitsuji Akazawa's contributions to pharmaceutical formulations demonstrate his dedication to innovation and improvement in medical products. His patents reflect a deep understanding of the complexities involved in creating effective and stable formulations. Akazawa continues to be a significant figure in the field, driving advancements that benefit the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
